Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA4575644
Max Phase: Preclinical
Molecular Formula: C34H47N5O6S
Molecular Weight: 653.85
Molecule Type: Unknown
Associated Items:
ID: ALA4575644
Max Phase: Preclinical
Molecular Formula: C34H47N5O6S
Molecular Weight: 653.85
Molecule Type: Unknown
Associated Items:
Canonical SMILES: C=C[C@]1(C)C[C@@H](OC(=O)CSc2nc(NC(=O)CN3CCOCC3)c3cc[nH]c3n2)[C@]2(C)[C@H](C)CC[C@]3(CCC(=O)[C@H]32)[C@@H](C)[C@@H]1O
Standard InChI: InChI=1S/C34H47N5O6S/c1-6-32(4)17-24(33(5)20(2)7-10-34(21(3)28(32)43)11-8-23(40)27(33)34)45-26(42)19-46-31-37-29-22(9-12-35-29)30(38-31)36-25(41)18-39-13-15-44-16-14-39/h6,9,12,20-21,24,27-28,43H,1,7-8,10-11,13-19H2,2-5H3,(H2,35,36,37,38,41)/t20-,21+,24-,27+,28+,32-,33+,34+/m1/s1
Standard InChI Key: WCHXDOBREGGHLM-KTLPEVPJSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Unknown | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 653.85 | Molecular Weight (Monoisotopic): 653.3247 | AlogP: 4.23 | #Rotatable Bonds: 8 |
Polar Surface Area: 146.74 | Molecular Species: NEUTRAL | HBA: 10 | HBD: 3 |
#RO5 Violations: 1 | HBA (Lipinski): 11 | HBD (Lipinski): 3 | #RO5 Violations (Lipinski): 2 |
CX Acidic pKa: 10.47 | CX Basic pKa: 5.07 | CX LogP: 4.13 | CX LogD: 4.13 |
Aromatic Rings: 2 | Heavy Atoms: 46 | QED Weighted: 0.16 | Np Likeness Score: 0.31 |
1. Deng Y, Wang XZ, Huang SH, Li CH.. (2019) Antibacterial activity evaluation of synthetic novel pleuromutilin derivatives in vitro and in experimental infection mice., 162 [PMID:30445267] [10.1016/j.ejmech.2018.11.006] |
Source(1):